Spyre Therapeutics
SYRE
SYRE
85 hedge funds and large institutions have $189M invested in Spyre Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 22 reducing their positions, and 9 closing their positions.
Holders
85
Holders Change
+8
Holders Change %
+10.39%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
18
Increased
26
Reduced
22
Closed
9
Calls
$263K
Puts
$248K
Net Calls
+$15K
Net Calls Change
-$75K
Top Buyers
Top Sellers
| 1 |
1
Adage Capital Partners
Boston,
Massachusetts
|
$4.75M |
| 2 |
O
2
OrbiMed
New York
|
$14M |
| 3 |
3
Millennium Management
New York
|
$905K |
| 4 |
ACM
4
Altium Capital Management
New York
|
$1.4M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$197K |
